0001437749-24-021086.txt : 20240624 0001437749-24-021086.hdr.sgml : 20240624 20240624161845 ACCESSION NUMBER: 0001437749-24-021086 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20240618 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Submission of Matters to a Vote of Security Holders ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240624 DATE AS OF CHANGE: 20240624 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PUMA BIOTECHNOLOGY, INC. CENTRAL INDEX KEY: 0001401667 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 770683487 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35703 FILM NUMBER: 241064499 BUSINESS ADDRESS: STREET 1: 10880 WILSHIRE BLVD. STREET 2: SUITE 2150 CITY: LOS ANGELES STATE: CA ZIP: 90024 BUSINESS PHONE: (424) 248-6500 MAIL ADDRESS: STREET 1: 10880 WILSHIRE BLVD. STREET 2: SUITE 2150 CITY: LOS ANGELES STATE: CA ZIP: 90024 FORMER COMPANY: FORMER CONFORMED NAME: INNOVATIVE ACQUISITIONS CORP DATE OF NAME CHANGE: 20070601 8-K 1 pbyi20240621_8k.htm FORM 8-K pbyi20240621_8k.htm
false 0001401667 0001401667 2024-06-18 2024-06-18
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): June 18, 2024
 
PUMA BIOTECHNOLOGY, INC.
(Exact Name of Registrant as Specified in its Charter)
         
Delaware
  
001-35703
  
77-0683487
(State or other jurisdiction
of incorporation)
  
(Commission
File Number)
  
(IRS Employer
Identification No.)
 
10880 Wilshire Boulevard, Suite 2150
Los Angeles, California 90024
(Address of principal executive offices) (Zip Code)
 
(424) 248-6500
(Registrant’s telephone number, including area code)
 
N/A
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
  
Trading
symbol
  
Name of each exchange
on which registered
Common Stock, par value $0.0001 per share
  
PBYI
  
The Nasdaq Stock Market LLC
(Nasdaq Global Select Market)
 
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
 
 
 
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers.
 
On June 18, 2024, Puma Biotechnology, Inc., a Delaware corporation (the “Company”) held its 2024 Annual Meeting of Stockholders (the “2024 Annual Meeting”) of the Company. At the 2024 Annual Meeting, the Company’s stockholders approved an amendment to the Puma Biotechnology, Inc. 2011 Incentive Award Plan, as amended (the “2011 Plan Amendment”). The 2011 Plan Amendment was adopted by the Company’s Board of Directors (the “Board”) on March 21, 2024.
 
The 2011 Plan Amendment amends the Company’s existing Puma Biotechnology, Inc. 2011 Incentive Award Plan (the “Plan” and as amended by the 2011 Plan Amendment, the “Amended Plan”) and makes the following material changes to the Plan:
 
 
(i)
Increases the number of shares of common stock available for issuance by 3,000,000 shares to an aggregate of 17,529,412 shares, and therefore increases the number of shares which may be granted as incentive stock options (“ISOs”) under the Amended Plan by 3,000,000 shares to an aggregate of 17,529,412 shares; and
 
 
(ii)
Extends the right to grant ISOs under the Amended Plan through March 21, 2034.
 
The 2011 Plan Amendment became effective on the date of the 2024 Annual Meeting on June 18, 2024.
 
The terms and conditions of the Amended Plan are described in the section entitled “Proposal 5 – Approval of an Amendment to the 2011 Incentive Award Plan” in the Company’s Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on April 26, 2024. The foregoing description of the 2011 Plan Amendment does not purport to be complete and is qualified in its entirety by reference to the complete text of the 2011 Plan Amendment, which is filed as Exhibit 10.1 hereto and is incorporated herein by reference.
 
Item 5.07. Submission of Matters to a Vote of Security Holders.
 
 
(a)
The Company held the 2024 Annual Meeting on June 18, 2024 at the Company’s principal executive offices, 10880 Wilshire Blvd., Suite 2150, Los Angeles, California.
 
 
(b)
The following proposals were voted upon at the 2024 Annual Meeting, and the final voting results with respect to each such proposal are set forth below:
 
Proposal 1:
The Company’s stockholders elected the eight nominated directors identified below, each to serve and to hold office for a one-year term until the close of the Company’s next annual meeting of stockholders in 2025 and until their successors have been duly elected and qualified or until their earlier resignation or removal.
 
Nominee
For
Withheld
Broker
Non-Votes
Alan H. Auerbach
31,690,323
470,271
8,522,633
Alessandra Cesano
26,273,431
5,887,163
8,522,633
Allison Dorval
31,249,555
911,039
8,522,633
Michael P. Miller
31,412,221
748,373
8,522,633
Jay M. Moyes
31,577,976
582,618
8,522,633
Adrian M. Senderowicz
31,614,630
545,964
8,522,633
Brian Stuglik
31,613,980
546,614
8,522,633
Troy E. Wilson
25,226,683
6,933,911
8,522,633
 
 
 
 
Proposal 2:
The Company’s stockholders ratified the selection of KPMG LLP as the Company’s independent registered accounting firm for the fiscal year ending December 31, 2024.
 
For
Against
Abstain
Broker
Non-Votes
40,225,891
401,633
55,703
0
 
Proposal 3:
The Company’s stockholders voted to approve, on an advisory basis, the compensation of the Company’s named executive officers.
 
For
Against
Abstain
Broker
Non-Votes
30,718,704
1,393,432
48,458
 8,522,633
 
Proposal 4:
The Company’s stockholders approved, on an advisory basis, a period of one year as the frequency of future advisory votes on the compensation of the Company’s named executive officers.
 
1 Year
2 Years
3 Years
Abstain
Broker
Non-Votes
31,098,916
27,632
785,779
248,267
8,522,633
 
Proposal 5:
The Company’s stockholders voted to approve an amendment to increase the number of shares of the Company’s common stock reserved for issuance under the Company’s 2011 Incentive Award Plan, as amended, by 3,000,000 shares and to extend the period during which ISOs may be granted.
 
For
Against
Abstain
Broker
Non-Votes
30,970,520
1,172,379
17,695
8,522,633
 
 
(c)
Not applicable.
 
 
(d)
Following the 2024 Annual Meeting, and consistent with the Board’s recommendation in the 2024 Proxy Statement, the Board has determined to hold future advisory votes on the compensation of the Company’s named executive officers on an annual basis.
 
Item 9.01 Financial Statements and Exhibits.
 
(d) Exhibits
 
 
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
 
 
 
 
SIGNATURE
 
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
PUMA BIOTECHNOLOGY, INC.
Date: June 24, 2024
By:
/s/ Alan H. Auerbach
Alan H. Auerbach
Chief Executive Officer and President
 
 
 
 EX-10.1 2 ex_691447.htm EXHIBIT 10.1 ex_691447.htm

Exhibit 10.1

 

SIXTH AMENDMENT TO

PUMA BIOTECHNOLOGY, INC.

2011 INCENTIVE AWARD PLAN

 

This Sixth Amendment (“Sixth Amendment”) to the Puma Biotechnology, Inc. 2011 Incentive Award Plan, as amended (the “Plan”), is adopted by the Board of Directors (the “Board”) of Puma Biotechnology, Inc., a Delaware corporation (the “Company”), effective as of June 18, 2024 (the “Amendment Effective Date”). Capitalized terms used in this Sixth Amendment and not otherwise defined herein shall have the meanings ascribed to such terms in the Plan.

 

RECITALS

 

A.

The Company currently maintains the Plan.

 

B.

Pursuant to Section 13.1 of the Plan, (i) the Board has the authority to amend the Plan at any time or from time to time, and (ii) the Board has the authority to amend the Plan to increase the limits imposed in Section 3.1 on the maximum number of shares which may be issued under the Plan (the “Share Limit”), subject to approval by the stockholders of the Company twelve (12) months before or after such action.

 

C.

The Board believes it is in the best interests of the Company and its stockholders to amend the Plan to (i) extend the period under which Incentive Stock Options (as defined in the Plan) may be granted under the Plan and (ii) increase the Share Limit.

 

AMENDMENT

 

 

The Plan is hereby amended as follows, effective as of the Amendment Effective Date:

 

 

1.

Section 2.19. Section 2.19 is hereby deleted and replaced in its entirety with the following:

 

 

“2.19 “Effective Date” shall mean June 18, 2024, provided, however, that solely for purposes of the last sentence of Section 13.1, the Effective Date shall be the date on which the Plan (as amended by the Sixth Amendment to the Plan) is adopted by the Board, subject to approval of the Plan (as amended by the Sixth Amendment to the Plan) by the Company’s stockholders.”

 

 

2.

Section 3.1(a). The first sentence of Section 3.1(a) of the Plan is hereby deleted and replaced in its entirety with the following:

 

 

“Subject to Sections 3.1(b), 13.1 and 13.2 hereof, the aggregate number of Shares which may be issued or transferred pursuant to Awards under the Plan shall be equal to 17,529,412 Shares (the “Share Limit”), all of which may be issued as Incentive Stock Options.”

 

 

3.

This Sixth Amendment shall be and, as of the Amendment Effective Date, is hereby incorporated in and forms a part of the Plan.

 

 

4.

Except as expressly provided herein, all terms and conditions of the Plan shall remain in full force and effect.

 

 

 
 EX-101.SCH 3 pbyi-20240618.xsd XBRL TAXONOMY EXTENSION SCHEMA 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink EX-101.DEF 4 pbyi-20240618_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 5 pbyi-20240618_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity [Domain] Legal Entity [Axis] Document Information [Line Items] Document Information [Table] Document, Type Document, Period End Date Entity, Registrant Name Entity, Incorporation, State or Country Code Entity, File Number Entity, Tax Identification Number Entity, Address, Address Line One Entity, Address, City or Town Entity, Address, State or Province Entity, Address, Postal Zip Code City Area Code Local Phone Number Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security Trading Symbol Security Exchange Name Entity, Emerging Growth Company Amendment Flag Entity, Central Index Key EX-101.PRE 6 pbyi-20240618_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 8 R1.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Document And Entity Information
Jun. 18, 2024
Document Information [Line Items]  
Entity, Registrant Name PUMA BIOTECHNOLOGY, INC.
Document, Type 8-K
Document, Period End Date Jun. 18, 2024
Entity, Incorporation, State or Country Code DE
Entity, File Number 001-35703
Entity, Tax Identification Number 77-0683487
Entity, Address, Address Line One 10880 Wilshire Boulevard, Suite 2150
Entity, Address, City or Town Los Angeles
Entity, Address, State or Province CA
Entity, Address, Postal Zip Code 90024
City Area Code 424
Local Phone Number 248-6500
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock
Trading Symbol PBYI
Security Exchange Name NASDAQ
Entity, Emerging Growth Company false
Amendment Flag false
Entity, Central Index Key 0001401667
EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.1.u2 html 1 22 1 false 0 0 false 0 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.pbyi.com/20240618/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false All Reports Book All Reports pbyi-20240618.xsd pbyi-20240618_def.xml pbyi-20240618_lab.xml pbyi-20240618_pre.xml pbyi20240621_8k.htm http://xbrl.sec.gov/dei/2023 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "pbyi20240621_8k.htm": { "nsprefix": "pbyi", "nsuri": "http://www.pbyi.com/20240618", "dts": { "schema": { "local": [ "pbyi-20240618.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/exch/2023/exch-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] }, "definitionLink": { "local": [ "pbyi-20240618_def.xml" ] }, "labelLink": { "local": [ "pbyi-20240618_lab.xml" ] }, "presentationLink": { "local": [ "pbyi-20240618_pre.xml" ] }, "inline": { "local": [ "pbyi20240621_8k.htm" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 26, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 22 }, "report": { "R1": { "role": "http://www.pbyi.com/20240618/role/statement-document-and-entity-information", "longName": "000 - Document - Document And Entity Information", "shortName": "Document And Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "d20248K", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "pbyi20240621_8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d20248K", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "pbyi20240621_8k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.pbyi.com/20240618/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.pbyi.com/20240618/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationLineItems", "presentation": [ "http://www.pbyi.com/20240618/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationTable", "lang": { "en-us": { "role": { "label": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.pbyi.com/20240618/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document, Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.pbyi.com/20240618/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document, Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.pbyi.com/20240618/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.pbyi.com/20240618/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.pbyi.com/20240618/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.pbyi.com/20240618/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.pbyi.com/20240618/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityDomain", "presentation": [ "http://www.pbyi.com/20240618/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity [Domain]", "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.pbyi.com/20240618/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.pbyi.com/20240618/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.pbyi.com/20240618/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.pbyi.com/20240618/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.pbyi.com/20240618/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LegalEntityAxis", "presentation": [ "http://www.pbyi.com/20240618/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.pbyi.com/20240618/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.pbyi.com/20240618/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.pbyi.com/20240618/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.pbyi.com/20240618/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.pbyi.com/20240618/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://www.pbyi.com/20240618/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.pbyi.com/20240618/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://www.pbyi.com/20240618/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 16 0001437749-24-021086-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001437749-24-021086-xbrl.zip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end XML 18 pbyi20240621_8k_htm.xml IDEA: XBRL DOCUMENT 0001401667 2024-06-18 2024-06-18 false 0001401667 8-K 2024-06-18 PUMA BIOTECHNOLOGY, INC. DE 001-35703 77-0683487 10880 Wilshire Boulevard, Suite 2150 Los Angeles CA 90024 424 248-6500 false false false false Common Stock PBYI NASDAQ false